Stock listing

Cellectar Biosciences, Inc.

Selected listing: NV40 · MUN · EUR · DE

Cellectar Biosciences, Inc. (Munich:NV40), Health Technology. Latest release Sep 29, 2026: Cellectar Biosciences to Present Compelling Efficacy Data…

NV40:MUNEURDEUpdated October 2, 2026

Ticker: Munich:NV40
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Munich
Currency: EUR

About Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. (ticker: CLRB) is a public company based in the United States, specializing in the development of targeted therapies for cancer. The company is committed to advancing its proprietary drug delivery platform to enhance the effectiveness of cancer therapies.

Latest news from Cellectar Biosciences, Inc.

Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia

September 28, 2026

Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia

September 29, 2026

Cellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

August 13, 2026

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026

July 30, 2026

Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers

July 15, 2026

All Cellectar Biosciences, Inc. news →

Events

Replays

Cellectar Biosciences, Inc. (CLRB) Q2 2026 Earnings Call
Thu, Aug 13, 2026 · 08:30 AM ET
Watch
Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call
Thu, May 14, 2026 · 08:30 AM ET
Watch
Cellectar Biosciences, Inc. (CLRB) Q4 2025 Earnings Call
Wed, Mar 04, 2026 · 08:30 AM ET
Watch

Research Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. company profile

View the public company page for Cellectar Biosciences, Inc. on 6ix.

Cellectar Biosciences, Inc. news

Read company news and market updates connected to Cellectar Biosciences, Inc..

Cellectar Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Cellectar Biosciences, Inc..